What's happening
This bill requires doctors to obtain signed informed consent from patients, including notification of risks, before prescribing psychiatric drugs.
Why it matters
Strengthens patient autonomy. by requiring doctors to provide clear information about the potential adverse effects and drug interactions before starting psychiatric medications, giving patients more control over their treatment decisions.
Increases transparency and accountability. in psychiatric care, as doctors must document that patients have been fully informed and have provided signed consent, which could help reduce misunderstandings or disputes about treatment risks.
May impact prescribing practices. by potentially making doctors more cautious or thorough when prescribing psychiatric drugs, possibly leading to more detailed discussions about alternatives and risks, as well as closer review of a patient’s current medications.
Could affect access to psychiatric medications. , especially in urgent or time-sensitive situations, as added procedural steps might delay the initiation of treatment for some patients.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Patients receiving psychiatric treatment
They would receive notice of possible adverse effects and interactions with their currently prescribed medications before giving signed informed consent for the listed drugs.
Psychiatrists
They would have to obtain prior notification and signed informed consent before prescribing antipsychotics, antidepressants, hallucinogens or mood stabilizers for psychiatric disorders or conditions.
Primary care doctors treating psychiatric conditions
The same notification and signed-consent requirements would apply when they prescribe any of the listed drugs, whether brand-name or generic.
Headline styles
Require Psychiatric Drug Warnings
Plain English, a few words. Used as the page title.
Sponsors
1 Multi-sponsor
History
- Held for consideration in higher education
- Referred to higher education
- Referred to higher education
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
2217
2017-2018 Regular Sessions
IN ASSEMBLY
January 17, 2017
Introduced by M. of A. MONTESANO -- Multi-Sponsored by -- M. of A. McDO- NOUGH, McKEVITT -- read once and referred to the Committee on Higher Education
AN ACT to amend the public health law, in relation to requiring notification and the informed consent of the patient prior to prescribing psychiatric drugs
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 3346 to read as follows:
§ 3346. Psychiatric drug informed consent. No doctor shall prescribe an antipsychotic, antidepressant, hallucinogen, or mood stabilizer drug, brand or generic, as defined in section thirty-three hundred six of this article, for the treatment of psychiatric disorders or conditions without the prior notification and the signed informed consent of the patient informing the patient of any possible adverse effects of the drug and the interaction with other medications the patient is currently prescribed.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD06078-01-7
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.